By indication / Peptide receptor radionuclide therapy

Peptide receptor radionuclide therapy

2 imaging agents and 32 therapeutic agents reported for this indication. Stage reflects how far each has been taken, not what is available in any given country.

Imaging

AgentIsotopeStageRuns
[68Ga]Ga-DOTATATE
paired with [177Lu]Lu-DOTATATE
Ga-68Approved26
[64Cu]Cu-sartate
paired with [67Cu]Cu-SARTATE
Cu-64Clinical research1

Therapy

AgentIsotopeStageRuns
[177Lu]Lu-DOTA-TOC
paired with [68Ga]Ga-DOTA-TOC
Lu-177—11
[177Lu]Lu-DOTATATE
paired with [68Ga]Ga-DOTATATE
Lu-177Approved10
[177Lu]Lu-DOTA-MGS5Lu-177Clinical research8
[212Pb]Pb-PSC-PEG2-TOCPb-212—6
[90Y]Y-DOTA-TOC
paired with [68Ga]Ga-DOTA-TOC
Y-90—6
[177Lu]Lu-DOTA-LM3Lu-177Clinical research6
[177Lu]Lu-CP04Lu-177—4
[225Ac]Ac-DOTATATE
paired with [68Ga]Ga-DOTATATE
Ac-225Clinical research4
[161Tb]Tb-DOTATATE
paired with [68Ga]Ga-DOTATATE
Tb-161Preclinical3
[177Lu]Lu-DOTA-JR11Lu-177Clinical research3
[177Lu]Lu-AMTGLu-177Clinical research3
[212Pb]Pb-DOTAMTATEPb-212Preclinical3
[177Lu]Lu-DOTA-PP-F11NLu-177Clinical research2
[90Y]Y-DOTATATE
paired with [68Ga]Ga-DOTATATE
Y-90—2
[161Tb]Tb-DOTA-TOC
paired with [68Ga]Ga-DOTA-TOC
Tb-161Preclinical2
[161Tb]Tb-DOTA-LM3Tb-161Clinical research2
[177Lu]Lu-DOTA-CCK-66Lu-177Preclinical2
[161Tb]Tb-3p-C-NETA
paired with [68Ga]Ga-3p-C-NETA
Tb-161Preclinical1
[225Ac]Ac-DOTA-LM3Ac-225Clinical research1
[90Y]Y-90-DOTATOC/DOTATATEY-90Clinical research1
[212Pb]Pb-DOTAM-GRPR1Pb-212Preclinical1
[153Sm]Sm-DOTATATE
paired with [68Ga]Ga-DOTATATE
Sm-153Preclinical
[225Ac]Ac-DOTA-TOC
paired with [68Ga]Ga-DOTA-TOC
Ac-225Clinical research
[213Bi]Bi-DOTA-TOC
paired with [68Ga]Ga-DOTA-TOC
Bi-213Clinical research
[90Y]Y-DOTA-DPhe1-Tyr3-octreotideY-90—
[177Lu]Lu-oxodotreotideLu-177—
[177Lu]Lu-EB-TATELu-177—
[177Lu]Lu-HA-DOTATATELu-177Clinical research
[90Y]Y-DOTA-Phe1-Tyr3-octreotideY-90Clinical research
[177Lu]Lu-LNC1010Lu-177Clinical research
[177Lu]Lu-177-OPS201Lu-177Preclinical
[177Lu]Lu-DOTA-EB-TATELu-177—

Other entries

AgentIsotopeStageRuns
[111In]In-APH070In-111Preclinical1
[177Lu]Lu-DOTA-cyclo-MG1Lu-177Preclinical1
[177Lu]Lu-DOTA-cyclo-MG2Lu-177Preclinical1
[177Lu]Lu-pentetreotideLu-177Clinical research
[212Pb]Pb-VMT-alpha-NETPb-212Clinical research

Have a question?Reagents, modules, introductions to manufacturers or to specialists in your region - tell us what you need.

Get in touch
Ask a question